Stay updated on ABP 654 for Psoriasis: Moderate-Severe Clinical Trial

Sign up to get notified when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now displays the ClinicalTrials.gov record for the completed ABP 654 plaque psoriasis study, including its design, eligibility criteria, locations, outcomes, and supporting documents.
    Difference
    97%
    Check dated 2026-11-08T13:47:52.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0. The page still displays a 403 Forbidden error instead of the study record.
    Difference
    0.3%
    Check dated 2026-11-01T15:01:52.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says federal agencies are using “Super Intelligence” (SI) in place of “Artificial Intelligence” (AI).
    Difference
    1%
    Check dated 2026-10-25T15:46:16.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-18T22:22:54.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The footer revision marker changed from v3.7.0 to v3.7.1, while the page remains a 403 error screen.
    Difference
    0.2%
    Check dated 2026-10-11T22:17:42.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study details, indicating the study record is currently inaccessible on the site.
    Difference
    19%
    Check dated 2026-09-20T22:32:50.000Z thumbnail image

Stay in the know with updates to ABP 654 for Psoriasis: Moderate-Severe Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.